To note, it has recently been discovered that the overexpression of CD147 may promote the acquisition of gemcitabine resistance by pancreatic tumor cells by interfering with the activation of p53 upon ATM/ATR/p53 complex formation, thus preventing cell apoptosis (REF: CD147). This evidence concerns the gene BSG and pancreatic neoplasm.